Insider · CIK 0001883311
Elly Keinan
Files at KD (Kyndryl Holdings, Inc.). First filing Nov 9, 2022, latest Nov 9, 2022.
In brief
Elly Keinan files SEC Form 4 as president at KD (Kyndryl Holdings, Inc.). Since Nov 9, 2022, Elly Keinan has reported 1 open-market buy worth $219k and 0 open-market sells worth $0, the latest filed on Nov 9, 2022.
A track record needs three past buys with six months of prices behind them; Elly Keinan has 0, so none is measured yet.
The newest scored trade: bought $219k of KD on Nov 9, 2022, filed Nov 9, 2022, scored 65 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KD: Kyndryl Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | Kyndryl Holdings, Inc. | $219k 23,800 shares | +4% | +9% from low-58% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 24, 2025 | CLBT CELLEBRITE DI LTD. | 508,790 0.21% of outstanding | $9.4M | Sep 24, 2025 | $112k |
| Sep 2, 2025 | CLBT Cellebrite DI Ltd. | 6,847 0.00% of outstanding | $112k | Sep 2, 2025 | $402k |
| Dec 11, 2024 | CLBT CELLEBRITE DI LTD | 19,385 0.01% of outstanding | $386k | Dec 11, 2024 | none |
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 1, 2026 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -34,645 | $13.48 | $467k | 1,568,330 | Aug 4, 2026 |
| Aug 1, 2026 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -27,506 | $13.48 | $371k | 1,540,824 | Aug 4, 2026 |
| Jun 3, 2026 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -13,894 | $12.25 | $170k | 1,602,975 | Jun 5, 2026 |
| Jun 1, 2026 | KD Kyndryl Holdings, Inc. | AGrant or award Common Stock | +248,032 | $0.00 | $0 | 1,628,122 | Jun 3, 2026 |
| Jun 2, 2026 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -11,253 | $12.62 | $142k | 1,616,869 | Jun 3, 2026 |
| May 28, 2026 | KD Kyndryl Holdings, Inc. | AGrant or award Common Stock | +309,440 | $0.00 | $0 | 1,538,876 | Jun 1, 2026 |
| May 28, 2026 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -158,786 | $12.16 | $1.9M | 1,380,090 | Jun 1, 2026 |
| Dec 16, 2025 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -23,686 | $26.37 | $625k | 1,229,436 | Dec 18, 2025 |
| Aug 1, 2025 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -35,678 | $36.58 | $1.3M | 1,281,448 | Aug 5, 2025 |
| Aug 1, 2025 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -28,326 | $36.58 | $1.0M | 1,253,122 | Aug 5, 2025 |
| Jun 2, 2025 | KD Kyndryl Holdings, Inc. | AGrant or award Common Stock | +81,396 | $0.00 | $0 | 1,098,461 | Jun 4, 2025 |
| Jun 2, 2025 | KD Kyndryl Holdings, Inc. | AGrant or award Common Stock | +232,559 | $0.00 | $0 | 1,331,020 | Jun 4, 2025 |
| Jun 3, 2025 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -13,894 | $39.43 | $548k | 1,317,126 | Jun 4, 2025 |
| May 29, 2025 | KD Kyndryl Holdings, Inc. | AGrant or award Common Stock | +492,495 | $0.00 | $0 | 1,289,416 | Jun 2, 2025 |
| May 29, 2025 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -272,351 | $38.76 | $11M | 1,017,065 | Jun 2, 2025 |
| Feb 1, 2025 | KD Kyndryl Holdings, Inc. | MOption exercise Common Stock | +110,142 | - | - | 853,987 | Feb 4, 2025 |
| Feb 1, 2025 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -57,066 | $37.70 | $2.2M | 796,921 | Feb 4, 2025 |
| Feb 1, 2025 | KD Kyndryl Holdings, Inc. | MOption exercise Performance Share Unitsderivative | -220,284 | - | - | 0 | Feb 4, 2025 |
| Dec 16, 2024 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -23,685 | $35.65 | $844k | 743,845 | Dec 18, 2024 |
| Aug 1, 2024 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -34,644 | $24.81 | $860k | 795,036 | Aug 5, 2024 |
| Aug 1, 2024 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -27,506 | $24.81 | $682k | 767,530 | Aug 5, 2024 |
| Jun 3, 2024 | KD Kyndryl Holdings, Inc. | AGrant or award Common Stock | +100,492 | $0.00 | $0 | 829,680 | Jun 5, 2024 |
| Dec 16, 2023 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -23,686 | $18.27 | $433k | 729,188 | Dec 19, 2023 |
| Nov 3, 2023 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -37,261 | $15.25 | $568k | 752,874 | Nov 7, 2023 |
| Dec 16, 2022 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -23,685 | $10.84 | $257k | 627,624 | Dec 20, 2022 |
| Nov 9, 2022 | KD Kyndryl Holdings, Inc. | POpen-market purchase Common Stock | +23,800 | $9.19 | $219k | 651,309 | Nov 9, 2022 |
| Nov 3, 2022 | KD Kyndryl Holdings, Inc. | FTax withholding Common Stock | -36,164 | $8.72 | $315k | 627,509 | Nov 7, 2022 |
Questions about Elly Keinan
Answered from the filings on this page, as of the latest one.
Is Elly Keinan buying or selling?
Not in the last 12 months. Elly Keinan's latest open-market trade on SEC Form 4 was bought $219k of KD on Nov 9, 2022.
How did Elly Keinan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elly Keinan has 0.
Where does Elly Keinan file Form 4?
Elly Keinan has filed Form 4 at KD (Kyndryl Holdings, Inc.) as Group President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.